The News Scroll 29 April 2020  Last Updated at 12:29 pm | Source: PTI

IIT Guwahati collaborates with Hester Biosciences to develop COVID-19 vaccine

IIT Guwahati collaborates with Hester Biosciences to develop COVID-19 vaccine
outlookindia.com
1970-01-01T05:30:00+0530
New Delhi, Apr 29 (PTI) Ahmedabad-based pharmaceutical firm Hester Biosciences on Wednesday said it has collaborated with Indian Institute of Technology Guwahati (IITG) to develop a vaccine for COVID-19.

The agreement between the two organisations was signed on April 15, 2020.

The vaccine will be based on recombinant avian paramyxovirus-based vector platform, the company said.

The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2, which could then be used as a vaccine candidate for further study.

The role of the institute is to produce the recombinant vaccine candidate.

“IITG and Hester have collaborated to develop and manufacture a recombinant vaccine against COVID-19 disease as a preventive measure. Hester’s involvement would be from master seed development up to release of the commercial vaccine," Rajiv Gandhi, CEO and MD, Hester Biosciences said.

Head of the research team Sachin Kumar, who is Associate Professor in the Department of Biosciences and Bioengineering at IIT Guwahati, said “It is too early to comment on the efficacy and immunogenicity of the vaccine, however, we will be able to reveal more details about this vaccine after the results of animal studies are obtained”. PTI SID SID ANS ANS


Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI
Next Story : TN govt to relax lockdown in three cities from Thursday
Download the Outlook ​Magazines App. Six magazines, wherever you go! Play Store and App Store